Focal prostate cancer treatment study
Part of Cancer, Kidney & urinary clinical trials.
This study looks at outcomes after “focal therapy,” a type of treatment that targets only part of the prostate, for people with newly diagnosed or returning prostate cancer. It may help researchers understand how well this targeted approach works and for whom.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Be getting focal therapy for your prostate cancer now, OR have had focal therapy before
- Your prostate cancer should not have spread to distant parts of the body (no metastatic disease)
- Be able to complete the study questionnaires in English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks outcomes for men who choose cryotherapy (freezing cancer cells) to treat prostate cancer that hasn't spread. It helps doctors understand how well this treatment works.
This registry tracks men with early-stage prostate cancer who choose focal therapy—a targeted treatment that destroys only the cancer area while preserving healthy prostate tissue. The study helps doctors understand how well this approach works and its safety.
This study is tracking men who choose focal therapy (a targeted treatment) for their localized prostate cancer. It aims to learn how well this treatment works and how it affects quality of life.
This trial tests whether freezing only the cancer area in the prostate (focal cryotherapy) can control intermediate-risk prostate cancer. It aims to limit treatment to one tumor focus while closely checking results with targeted and follow-up testing.
This is a registry study for men with intermediate-risk prostate cancer who are getting a type of focal treatment (treating only the cancer spot, not the whole prostate). It collects data on treatments like HIFU, cryotherapy, and others to better understand their long-term results.
This study is a registry for people who have already had focal therapy (targeted treatment) for prostate cancer at Queen Mary Hospital. It aims to collect information about these treatments, which may help improve future care.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.